Literature DB >> 8244499

Childhood non-Hodgkins lymphoma.

S H Advani1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8244499     DOI： 10.1007/bf02822184

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  9 in total

Review 1.  Non-Hodgkin's lymphomas in children. I. Patterns of disease and classification.

Authors:  L White; S E Siegel; T C Quah
Journal:  Crit Rev Oncol Hematol       Date:  1992-07       Impact factor: 6.312

2.  Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution.

Authors:  S B Murphy; D L Fairclough; R E Hutchison; C W Berard
Journal:  J Clin Oncol       Date:  1989-02       Impact factor: 44.544

3.  A randomized trial of combined modality therapy of childhood non-Hodgkin's lymphoma.

Authors:  S B Murphy; H O Hustu
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860

Review 4.  Non-Hodgkin's lymphoma. Biologic classification and implication for therapy.

Authors:  J Kurtzberg; M L Graham
Journal:  Pediatr Clin North Am       Date:  1991-04       Impact factor: 3.278

5.  A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminary evaluation.

Authors:  M L de Andrea; B de Camargo; R Melaragno
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

Review 6.  NIH conference. A multidisciplinary approach to non-hodgkin's lymphomas.

Authors:  C W Berard; M H Greene; E S Jaffe; I Magrath; J Ziegler
Journal:  Ann Intern Med       Date:  1981-02       Impact factor: 25.391

7.  Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.

Authors:  C Patte; C Kalifa; F Flamant; O Hartmann; L Brugières; D Valteau-Couanet; C Bayle; J M Caillaud; J Lemerle
Journal:  Med Pediatr Oncol       Date:  1992

8.  Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study Group.

Authors:  A T Meadows; R Sposto; R D Jenkin; J H Kersey; R R Chilcote; S E Siegel; P F Coccia; J Rosenstock; K C Pringle; C J Stolar
Journal:  J Clin Oncol       Date:  1989-01       Impact factor: 44.544

9.  Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).

Authors:  M P Sullivan; J Boyett; J Pullen; W Crist; E J Doering; R Trueworthy; E Hvizdala; F Ruymann; C P Steuber
Journal:  Cancer       Date:  1985-01-15       Impact factor: 6.860
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.